Understanding Your Child's STAT5B Diagnosis
At a Glance
STAT5B deficiency is a rare genetic condition that affects both growth hormone signaling and immune regulation. Children may have growth failure, infections, inflammation, or lung disease, so care should include coordinated monitoring by endocrinology, immunology, and genetics.
Receiving a diagnosis of STAT5B deficiency—now more accurately termed STAT5B-related growth hormone insensitivity with immune dysregulation—often marks the end of a long and exhausting search for answers [1][2]. For many parents, this “diagnostic odyssey” involves years of specialists, repeated testing, and the heavy burden of knowing something is wrong without having a name for it [3][4]. It is normal to feel a complex mix of relief that the search is over, alongside grief, anxiety, or guilt about the road ahead [2][5]. This condition is ultra-rare, meaning you are navigating a path that few families have walked, but understanding the biology of the diagnosis is the first step in moving from uncertainty to a clear care plan [6][7].
What is STAT5B Deficiency?
STAT5B deficiency is a rare genetic disorder that affects both how a child grows and how their immune system functions [8][9]. To understand it, it helps to look at the “signaling chain” in the body. Normally, growth hormone (GH) acts like a key that fits into a lock (the receptor) on the surface of cells [9]. Once the lock is turned, a protein called STAT5B acts as a messenger, traveling to the cell’s command center to tell it to produce IGF-I (Insulin-like Growth Factor-1), the primary driver of bone and tissue growth [8][10].
In children with this condition, the STAT5B “messenger” is missing or altered. Because the message is impaired, the body reduces its production of IGF-I and its response to GH, often leading to severe growth failure postnatally [11]. Even though the body may be making normal or even elevated amounts of growth hormone, the cells are “insensitive” to it because the internal messenger system is faulty [8][12].
The Difference Between STAT5B and Classic Laron Syndrome
You may hear this condition referred to by its historical name, “Laron syndrome with immunodeficiency,” but they are fundamentally different conditions. It is vital for your care team to recognize these distinctions:
- Classic Laron Syndrome: This is usually caused by a problem with the “lock” (Growth Hormone Receptor or GHR) [9][13]. While it causes similar severe short stature, it generally does not affect the immune system [14].
- STAT5B Deficiency: Because the STAT5B protein has a second, crucial job in the immune system, its absence affects more than just growth [15][16].
In short, while both conditions result in low IGF-I and growth failure, STAT5B deficiency is a multisystem disorder that requires an immunologist as well as an endocrinologist [17][16].
The Dual Nature of the Condition
The typical course of STAT5B deficiency involves two parallel challenges: growth failure and immune dysregulation [11][18].
Postnatal Growth Failure
Many children with this condition experience postnatal growth failure, meaning they may be born at a typical size but their growth rate slows significantly after birth [11]. Because the body is “growth hormone insensitive,” standard growth hormone injections are typically not effective. Instead, treatment may involve replacing the missing IGF-I directly, though this is heavily individualized [10][8].
Immune System Dysregulation
The STAT5B protein is essential for the health of several types of immune cells, including T-regulatory cells (which help control the immune response) and Natural Killer (NK) cells (which fight viruses) [15][16][17]. This dysfunction can lead to several issues:
- Chronic Infections: Frequent or unusual infections, particularly in the lungs [16][9].
- Autoimmunity and Inflammation: The immune system may become dysregulated, leading to conditions like severe eczema (chronic skin inflammation), autoimmune lung disease, or chronic diarrhea [19][15].
- Lung Health: Chronic pulmonary (lung) disease is a serious potential complication of the immune deficiency and requires close monitoring based on symptoms [17][9].
Navigating the Spectrum of Variants
The severity of the condition can vary widely based on the specific genetic change.
- Recessive (Biallelic) Variants: When a child inherits an altered copy of the gene from both parents, the symptoms are typically more severe, often including profound growth failure and significant immune/lung issues [8][9].
- Dominant-Negative Variants: In some cases, a single altered copy of the gene can interfere with the working copy. These children may have milder growth failure and skin issues (like eczema) [20][11].
Note on Variability: It is critical to understand that while the variant class (recessive vs. dominant-negative) informs a patient’s risk profile, it does not guarantee an individual child’s course. Biallelic disease can be highly variable, and dominant-negative variants do not entirely exclude the possibility of immune dysregulation, autoimmunity, or infections. A reassuring genetic variant label does not eliminate the need to report breathing or infection symptoms to your doctor immediately [21][18].
Understanding which form your child has will help you and your doctors tailor their monitoring and care [21]. While the diagnosis is rare, it provides a roadmap for protecting your child’s health across both their growth and their immune system [2].
Common questions in this guide
What does a STAT5B deficiency diagnosis mean for my child?
How is STAT5B deficiency different from classic Laron syndrome?
What immune problems should I watch for with STAT5B deficiency?
Will growth hormone injections help a child with STAT5B deficiency?
What can genetic testing tell us about my child's STAT5B variant?
Which specialists should coordinate my child's STAT5B care?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Understanding variant types
Could you explain whether our child's variant is recessive or dominant-negative?
Symptoms to report
Which breathing or infection symptoms should we report right away?
Variability in outcomes
Does a variant label tell us how our child's immune system may be affected?
Get notified when new evidence is published on Laron syndrome with immunodeficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (21)
- 1
Facing the challenges to shorten the diagnostic odyssey: first Whole Genome Sequencing experience of a Colombian cohort with suspected rare diseases.
Velasco HM, Bertoli-Avella A, Jaramillo CJ, et al.
European journal of human genetics : EJHG 2024; (32(10)):1327-1337 doi:10.1038/s41431-024-01609-8.
PMID: 38909121 - 2
Evaluation of the parents' anxiety levels before and after the diagnosis of their child with a rare genetic disease: the necessity of psychological support.
Kolemen AB, Akyuz E, Toprak A, et al.
Orphanet journal of rare diseases 2021; (16(1)):402 doi:10.1186/s13023-021-02046-2.
PMID: 34583726 - 3
Clinical whole genome sequencing as a first-tier test at a resource-limited dysmorphology clinic in Mexico.
Scocchia A, Wigby KM, Masser-Frye D, et al.
NPJ genomic medicine 2019; (4()):5 doi:10.1038/s41525-018-0076-1.
PMID: 30792901 - 4
Children with a rare congenital genetic disorder: a systematic review of parent experiences.
von der Lippe C, Neteland I, Feragen KB
Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.
PMID: 36253830 - 5
Carer burden in rare inherited diseases: a literature review and conceptual model.
Sandilands K, Williams A, Rylands AJ
Orphanet journal of rare diseases 2022; (17(1)):428 doi:10.1186/s13023-022-02561-w.
PMID: 36494728 - 6
Assessing Psychological Harms on Parents and Primary Caregivers of Children Living with a Rare Disease: A Systematic Review of the Scope and Validity of Surveys Utilized.
Bull LJ, Eslick GD, Teutsch SM, Elliott EJ
Clinical child and family psychology review 2025; (28(3)):612-630 doi:10.1007/s10567-025-00533-7.
PMID: 40588644 - 7
Comparison of parental caregivers and associated factors with caregiver burden in rare paediatric diseases.
Brandt M, Inhestern L, Zybarth D, et al.
Orphanet journal of rare diseases 2026; (21(1)).
PMID: 42881418 - 8
An in vivo functional assay to characterize human STAT5B genetic variants during zebrafish development.
Landi E, Karabatas L, Rodríguez Gomez T, et al.
Human molecular genetics 2023; (32(15)):2473-2484 doi:10.1093/hmg/ddad078.
PMID: 37162340 - 9
STAT5B deficiency: Impacts on human growth and immunity.
Hwa V
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2016; (28()):16-20.
PMID: 26703237 - 10
Recombinant Human Insulin-Like Growth Factor-1 Treatment of Severe Growth Failure in Three Siblings with STAT5B Deficiency.
Muthuvel G, Al Remeithi SS, Foley C, et al.
Hormone research in paediatrics 2024; (97(2)):195-202 doi:10.1159/000531491.
PMID: 37586336 - 11
Human growth disorders associated with impaired GH action: Defects in STAT5B and JAK2.
Hwa V
Molecular and cellular endocrinology 2021; (519()):111063 doi:10.1016/j.mce.2020.111063.
PMID: 33122102 - 12
A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
Ramírez L, Sanguineti N, Scaglia P, et al.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2020; (50()):61-70 doi:10.1016/j.ghir.2019.12.005.
PMID: 31902742 - 13
Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.
Hinrichs A, Kessler B, Kurome M, et al.
Molecular metabolism 2018; (11()):113-128 doi:10.1016/j.molmet.2018.03.006.
PMID: 29678421 - 14
Long-term follow-up of STAT5B deficiency in three argentinian patients: clinical and immunological features.
Bezrodnik L, Di Giovanni D, Caldirola MS, et al.
Journal of clinical immunology 2015; (35(3)):264-72 doi:10.1007/s10875-015-0145-5.
PMID: 25753012 - 15
IL-2 Signaling Axis Defects: How Many Faces?
Consonni F, Favre C, Gambineri E
Frontiers in pediatrics 2021; (9()):669298 doi:10.3389/fped.2021.669298.
PMID: 34277517 - 16
Developmental Adaptive Immune Defects Associated with STAT5B Deficiency in Three Young Siblings.
Foley CL, Al Remeithi SS, Towe CT, et al.
Journal of clinical immunology 2021; (41(1)):136-146 doi:10.1007/s10875-020-00884-6.
PMID: 33090292 - 17
Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function.
Vargas-Hernández A, Witalisz-Siepracka A, Prchal-Murphy M, et al.
The Journal of allergy and clinical immunology 2020; (145(1)):345-357.e9 doi:10.1016/j.jaci.2019.09.016.
PMID: 31600547 - 18
Atypical STAT5B deficiency, severe short stature and mild immunodeficiency associated with a novel homozygous STAT5B Variant.
Catli G, Gao W, Foley C, et al.
Molecular and cellular endocrinology 2023; (559()):111799 doi:10.1016/j.mce.2022.111799.
PMID: 36265659 - 19
STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases.
Lorenzini T, Dotta L, Giacomelli M, et al.
Journal of leukocyte biology 2017; (101(1)):29-38 doi:10.1189/jlb.5RI0516-237RR.
PMID: 27803128 - 20
Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation.
Klammt J, Neumann D, Gevers EF, et al.
Nature communications 2018; (9(1)):2105 doi:10.1038/s41467-018-04521-0.
PMID: 29844444 - 21
STAT wars: how STATopathies sabotage innate immunity.
Bloomfield M, Šabatková K, Paračková Z
Current opinion in allergy and clinical immunology 2026; (26(2)):113-121 doi:10.1097/ACI.0000000000001139.
PMID: 41505725
This page explains STAT5B-related growth hormone insensitivity and immune dysregulation for informational purposes only and does not replace medical advice. Your child's endocrinology, immunology, and genetics team should interpret the diagnosis and plan care.